The influence of BRCA2 mutation on localized prostate cancer.

Taylor, Renea A; Fraser, Michael; Rebello, Richard J; Boutros, Paul C; Murphy, Declan G; Bristow, Robert G; Risbridger, Gail P

Taylor, Renea A; Fraser, Michael; Rebello, Richard J; Boutros, Paul C; Murphy, Declan G; Bristow, Robert G; Risbridger, Gail P.

Afiliação

Taylor RA; Monash Partners Comprehensive Cancer Consortium and Cancer Program, Biomedicine Discovery Institute, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology and Department of Physiology, Monash University, Melbourne, Victoria, Australia.
Fraser M; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Rebello RJ; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Boutros PC; Translational Oncogenomics Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre, Manchester, UK.
Murphy DG; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Bristow RG; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Risbridger GP; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.

Nat Rev Urol ; 16(5): 281-290, 2019 05.

Article em En | MEDLINE | ID: mdl-30808988

Assuntos

Proteína BRCA2/genética; Mutação; Neoplasias da Próstata/genética; Humanos; Masculino; Neoplasias da Próstata/patologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Proteína BRCA2 / Mutação Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google